News about Global Pharma

Bio-Thera, STADA Expand Biosimilars Alliance to Include Tocilizumab

Bio-Thera Solutions and STADA Arzneimittel have extended their biosimilars alliance to include tocilizumab, with Bio-Thera handling development and supply while STADA secures exclusive commercialization rights across Europe and select markets.

Global Pharma | 25/08/2025 | By Mrinmoy Dey |  269

Collaboration is Key to Resilient Medical Device Ecosystem: Pharma Secretary

Amit Agrawal, Secretary of the Department of Pharmaceuticals, has emphasised the need to strengthen the medical device sector ecosystem not only through technology and skilled manpower, but also by establishing “internationally accredited laboratories, adopting globally harmonised standards and supporting clinical investigations for innovative devices.”

Global Pharma | 25/08/2025 | By Dineshwori |  155

Akums to Set Up Manufacturing Facility in Zambia

Akums Drugs and Pharmaceuticals has signed a framework agreement with the Government of the Republic of Zambia to establish a local manufacturing facility in the country and supply essential medicines.

Global Pharma | 25/08/2025 | By Dineshwori |  415

Gyre Therapeutics Appoints Dan Weng to Board of Directors

Gyre Therapeutics, a US-based commercial-stage biopharmaceutical company focused on innovative therapies for organ fibrosis, has announced the appointment of Dr. Dan Weng, former CEO of Medelis, to its Board of Directors.

Global Pharma | 22/08/2025 | By Dineshwori |  347

ANGLE Forms Strategic Collaboration with Myriad Genetics

ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.

Global Pharma | 22/08/2025 | By Mrinmoy Dey |  169

Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli

Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.

Global Pharma | 22/08/2025 | By Dineshwori |  252

BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery

BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.

Global Pharma | 21/08/2025 | By Dineshwori |  748

LSPedia Partners with Spring Bio Solution to Advance Pharma Traceability in India

LSPedia has partnered with India-based Spring Bio Solution to expand global adoption of its OneScan pharmaceutical compliance and track-and-trace platform.

Global Pharma | 21/08/2025 | By Mrinmoy Dey |  276

NATCO Launches Tracleer Generic in US with Lupin

NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.

Global Pharma | 20/08/2025 | By Dineshwori |  381

Alembic Pharma Receives USFDA Final Approval for Macitentan Tablets, 10 mg

Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.

Global Pharma | 20/08/2025 | By Dineshwori |  470